Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

David F. McDermott, Mahrukh A. Huseni, Michael B. Atkins et al. · Nature Medicine · 2018

Cited by 1,254 works. doi:10.1038/s41591-018-0053-3

Authors

References